Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

  • STATUS
    Recruiting
  • End date
    Dec 31, 2027
  • participants needed
    62
  • sponsor
    Institute of Oncology Ljubljana
Updated on 29 September 2021

Summary

The purpose of the study is to identify the most promising sequence of modalities in total neoadjuvant treatment of localy advanced rectal cancer with high risk of recurrence

Description

International recommendations for the treatment of LARC with a high risk of disease recurrence are inconsistent, regarding TNT. In Germain randomised study more pCR were achieved with consolidation chemotherapy. We will compare our standard approach (induction plus consolidation CT) with consolidation CT.

Details
Condition Locally Advanced Rectal Cancer
Treatment induction chemotherapy, Consolidation chemotherapy
Clinical Study IdentifierNCT05054959
SponsorInstitute of Oncology Ljubljana
Last Modified on29 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

histologically proven rectal adenocarcinoma
no distant metastases on CT scan (M0 disease)
at least one high risk factor for disease recurrence identified on MR imaging
T4 tumor (cT4)
N2 disease (cN2)
extramural venous invasion (cEMVI+)
positive lateral lymph nodes
distance of tumor to mesorectal fascia or positive lymph nodes is 1 mm or less (cMRF+)
capacity for informed consent
willingness to attend regular check-ups during and after treatment

Exclusion Criteria

history of previous irradiation in the pelvic area
absolute contraindications for MR imaging
distant metastases cannot be reliably excluded
synchronous cancer
chronic inflammatory bowel disease
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note